Hui-Hsuan Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Hui-Hsuan Liu has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Charlotte Lawson
Department of Comparative Biomedical Sciences, Royal Veterinary College, London NW1 0TU, UK
1 shared publication - David J. Connolly
Affiliation Department of Clinical Science and Services, Royal Veterinary College, Hatfield, Hertfordshire, United Kingdom
1 shared publication - Jayesh Dudhia
Department of Clinical Sciences and Services, Royal Veterinary College, London, United Kingdom
1 shared publication - Lois Wilkie
Department of Clinical Science and Services, Royal Veterinary College, Hatfield AL9 7TA, UK
1 shared publication - Melanie Jo Dobromylskyj
Finn Pathologists, Norfolk, UK
1 shared publication - Virginia Luis Fuentes
Department of Clinical Science and Services, Royal Veterinary College , Hatfield AL9 7TA
1 shared publication
Latest Publications
- Open Access
Exploration of Mediators Associated with Myocardial Remodelling in Feline Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy (HCM) affects both humans and cats and exhibits considerable interspecies similarities that are exemplified by underlying pathological processes and clinical presentation to the extent that developments in the human field may have direct relevance to the feline disease. Characteristic changes on histological examination include cardiomyocyte hypertrophy and interstitial and replacement fibrosis. Clinically, HCM is characterised by significant diastolic dysfunction due to a reduction in ventricular compliance and relaxation associated with extracellular matrix (ECM) remodelling and the development of ventricular hypertrophy. Studies in rodent models and human HCM patients have identified key protein mediators implicated in these pathological changes, including lumican, lysyl oxidase and TGF-β isoforms. We therefore sought to quantify and describe the cellular location of these mediators in the left ventricular myocardium of cats with HCM and investigate their relationship with the quantity and structural composition of the ECM. We identified increased myocardial content of lumican, LOX and TGF-β2 mainly attributed to their increased expression within cardiomyocytes in HCM cats compared to control cats. Furthermore, we found strong correlations between the expressions of these mediators that is compatible with their role as important components of cellular pathways promoting remodelling of the left ventricular myocardium. Fibrosis and hypertrophy are important pathological changes in feline HCM, and a greater understanding of the mechanisms driving this pathology may facilitate the identification of potential therapies.
Open AccessExploration of Mediators Associated with Myocardial Remodelling in Feline Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy (HCM) affects both humans and cats and exhibits considerable interspecies similarities that are exemplified by underlying pathological processes and clinical presentation to the extent that developments in the human field may have direct relevance to the feline disease. Characteristic changes on histological examination include cardiomyocyte hypertrophy and interstitial and replacement fibrosis. Clinically, HCM is characterised by significant diastolic dysfunction due to a reduction in ventricular compliance and relaxation associated with extracellular matrix (ECM) remodelling and the development of ventricular hypertrophy. Studies in rodent models and human HCM patients have identified key protein mediators implicated in these pathological changes, including lumican, lysyl oxidase and TGF-β isoforms. We therefore sought to quantify and describe the cellular location of these mediators in the left ventricular myocardium of cats with HCM and investigate their relationship with the quantity and structural composition of the ECM. We identified increased myocardial content of lumican, LOX and TGF-β2 mainly attributed to their increased expression within cardiomyocytes in HCM cats compared to control cats. Furthermore, we found strong correlations between the expressions of these mediators that is compatible with their role as important components of cellular pathways promoting remodelling of the left ventricular myocardium. Fibrosis and hypertrophy are important pathological changes in feline HCM, and a greater understanding of the mechanisms driving this pathology may facilitate the identification of potential therapies.